The Centers for Medicare & Medicaid Services today issued guidance on designing state approaches to covering treatment services for Medicaid-eligible infants with neonatal abstinence syndrome. “Through discussions with states, we have recognized their growing challenge in providing treatment services to the expanding number of infants with NAS,” said Tim Hill, acting director of the Center for Medicaid and CHIP Services. “We have also recognized that states may not be fully aware of available options under Medicaid that can play a critical role in the care of these infants, as well as the limitations on Medicaid coverage.” In addition, CMS issued a letter to state Medicaid directors on funding authorities that may support health information technology efforts to address the opioid crisis.

Related News Articles

Headline
The Substance Abuse and Mental Health Services Administration will launch a three-part virtual learning series on recovery supports for people considering or…
Headline
The Centers for Medicare…
Headline
Drug overdose deaths declined 5.1% in 2018 to about 68,000, according to preliminary data from the Centers for Disease Control and Prevention.
Headline
Under a new Centers for Medicare…
Headline
The Centers for Medicare…
Headline
The House Energy and Commerce Subcommittee on Health today passed the No Surprises Act (H.R. 3630), bipartisan legislation that would prohibit balance billing…